Literature DB >> 15265715

Cryoinjury in endothelial cell monolayers.

Stacey L Ebertz1, Locksley E McGann.   

Abstract

Developing successful cryopreservation strategies for corneas have proven to be more difficult than anticipated, because of the resulting loss of viability and detachment of endothelial cells from Descemet's membrane following cryopreservation of corneas. The objectives of this study are to develop a more detailed understanding of cryoinjury in human corneal endothelial cell (HCEC) monolayers and to examine the effects of storage temperature, cryoprotectant type and concentration, and cooling/warming rates on HCEC monolayers. Monolayers of endothelial cells attached to collagen-coated glass, immersed in an experimental solution (with and without cryoprotectant) were cooled at 1 degrees C/min to various temperatures (-5 to -40 degrees C), then thawed directly or cooled rapidly to -196 or to -80 degrees C before thawing. Cryoprotectants used were dimethyl sulfoxide and propylene glycol in concentrations of 1 and 2M. Monolayers were assessed for membrane integrity and detachment using SYTO/ethidium bromide fluorescent stain. The presence of cryoprotectants resulted in high recovery of membrane integrity and low monolayer detachment in monolayers thawed directly from temperatures down to -40 degrees C. In contrast, there was excessive detachment and loss of membrane integrity in monolayers cooled to -196 degrees C compared to monolayers cooled to -80 degrees C. Also, increasing cryoprotectant concentrations did not improve recovery of the monolayers. The higher recovery and lower detachment after storage at -80 degrees C compared to storage at -196 degrees C suggest that storage temperatures for corneas should be re-evaluated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265715     DOI: 10.1016/j.cryobiol.2004.04.003

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  6 in total

1.  Pollen derived macromolecules serve as a new class of ice-nucleating cryoprotectants.

Authors:  Kathryn A Murray; Nina L H Kinney; Christopher A Griffiths; Muhammad Hasan; Matthew I Gibson; Thomas F Whale
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

2.  Xenotransplantation of cryopreserved human clumps of mesenchymal stem cells/extracellular matrix complexes pretreated with IFN-γ induces rat calvarial bone regeneration.

Authors:  Tomoya Ogawa; Mikihito Kajiya; Susumu Horikoshi; Hiroki Yoshii; Mai Yoshino; Souta Motoike; Shin Morimoto; Hisakatsu Sone; Tomoyuki Iwata; Kazuhisa Ouhara; Shinji Matsuda; Noriyoshi Mizuno
Journal:  Regen Ther       Date:  2022-04-28       Impact factor: 3.651

3.  Development of polymer based cryogel matrix for transportation and storage of mammalian cells.

Authors:  Jyoti Kumari; Ashok Kumar
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

4.  Cryopreserved clumps of mesenchymal stem cell/extracellular matrix complexes retain osteogenic capacity and induce bone regeneration.

Authors:  Souta Motoike; Mikihito Kajiya; Nao Komatsu; Manabu Takewaki; Susumu Horikoshi; Shinji Matsuda; Kazuhisa Ouhara; Tomoyuki Iwata; Katsuhiro Takeda; Tsuyoshi Fujita; Hidemi Kurihara
Journal:  Stem Cell Res Ther       Date:  2018-03-21       Impact factor: 6.832

5.  Towards ready-to-use 3-D scaffolds for regenerative medicine: adhesion-based cryopreservation of human mesenchymal stem cells attached and spread within alginate-gelatin cryogel scaffolds.

Authors:  Alisa Katsen-Globa; Ina Meiser; Yuriy A Petrenko; Roman V Ivanov; Vladimir I Lozinsky; Heiko Zimmermann; Alexander Yu Petrenko
Journal:  J Mater Sci Mater Med       Date:  2013-12-03       Impact factor: 3.896

6.  Cryopreservation of primary cultures of mammalian somatic cells in 96-well plates benefits from control of ice nucleation.

Authors:  Martin I Daily; Thomas F Whale; Riitta Partanen; Alexander D Harrison; Peter Kilbride; Stephen Lamb; G John Morris; Helen M Picton; Benjamin J Murray
Journal:  Cryobiology       Date:  2020-02-21       Impact factor: 2.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.